RHOPRESSA

This brand name is authorized in United States.

Active ingredients

The drug RHOPRESSA contains one active pharmaceutical ingredient (API):

`1`	Netarsudil UNII `VL756B1K0U` - NETARSUDIL MESYLATE
	Netarsudil, a Rho kinase inhibitor, is believed to reduce intraocular pressure (IOP) by increasing outflow of aqueous humor. Studies in animal and man suggest that the main mechanism of action is increased trabecular outflow. These studies also suggest that netarsudil lowers IOP by reducing episcleral venous pressure.
	Read more about Netarsudil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RHOPRESSA Ophthalmic solution	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	70727-497

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.